glp 1 or sglt2 Scripts for GLP-1, Drugs on the Rise in Type Diabetes Patients SGLT2i and GLP-1 RA therapy

While various studies have examined the effects of GLP-1 agonists in obesity, two notable phase 3 trials are worth highlighting in this context

In addition, histopathology was conducted at 24 mo of age or end of life, as described below

For research requiring extended administration, Ipamorelin is strongly preferred

Overall, the benefits of using BPC-157 Thymosin Beta 4 peptide capsules include improved stability, absorption, convenience, and practicality for researchers investigating peptide therapy

doi: 10.1186/s10194-025-01979-4 Hidayat K, Zhou YY, Du HZ, Qin LQ, Shi BM, Li ZN

The next two are actually, because they are so cross-correlated you can't actually distinguish which one is more important, are hypertension and elevated ApoB or LDL particle number